Clinical trials build expertise with new treatments before they’re widely available

At Norton Cancer Institute, we are committed to giving our patients the opportunity to receive state-of-the-art, cutting-edge therapies. This is made possible because of the long-standing support of clinical trials by Norton Healthcare’s leadership and [...]

View more

Advances in early detection of ovarian cancer

Ovarian cancer is personal to me. Two of my mom’s sisters died of the disease. One of the major issues with successfully treating ovarian cancer is how late it is typically diagnosed: stage IIIC. At […]

View more

Gynecologic oncologist Justin W. Gorski, M.D., Ph.D., joins Norton Cancer Institute

Justin W. Gorski, M.D., Ph.D., has joined Norton Cancer Institute, specializing in treating cancers of the female reproductive system, including ovarian, uterine and cervical cancers. Dr. Gorski is a board-certified gynecologic oncologist. He received his […]

View more

Advancing the standard of cancer care and offering patients access to new therapies

Our goal is to offer every patient the option of the latest treatment available for their cancer. To do that, Norton Cancer Institute is participating in approximately 170 clinical trials at any time. These clinical [...]

View more

Addressing emotional health is a vital part of cancer care

Cancer is a disease that impacts each individual differently. There is no one-size-fits-all approach to compassion and care. Just as we deliver individualized medicine, we deliver individualized care to ensure we meet the needs of […]

View more

Freezing giant cell tumor of bone: Case study

The patient A 25-year-old woman presented with recurrent left second metacarpal giant cell tumor of bone. She previously was treated with extensive curettage, bone graft substitute placement and Kirschner wire fixation. Giant cell tumor of [...]

View more

Amplified cardiopulmonary recordings as a music therapy intervention

Bereaved family members of adult oncology patients appear to have moderate acceptance and use of amplified cardiopulmonary recordings (ACPR) when created in the context of ongoing music therapy treatment, according to a recently published study. […]

View more

Mia Jusufbegovic, M.D., joins Norton Cancer Institute

Mia Jusufbegovic, M.D., has joined Norton Cancer Institute as its first head and neck oncology and microvascular reconstructive surgeon treating complex ear, nose and throat oncology cases. Dr. Jusufbegovic earned her medical degree from the […]

View more

Cancer care disparities in Kentucky

Kentucky leads the nation in cases of lung cancer. Cancer patients in our region also experience barriers to care and racial disparities in care. In a recent presentation on pursuing health equity in lung cancer […]

View more

Updates in screening and treatment of leading gastrointestinal cancers

Gastrointestinal cancers can occur anywhere from the esophagus to the anus and in attached structures such as the pancreas and liver. They include the second- and third-deadliest cancers in the United States. Not counting skin [...]

View more

Douglas A. Nelson, M.D., joins Norton Cancer Institute

Douglas A. Nelson, M.D., has joined Norton Cancer Institute, practicing at the downtown Louisville and St. Matthews offices. Dr. Nelson most recently was an associate professor in the Department of Gastrointestinal Medical Oncology and Department [...]

View more

Clinical trial summary: Venetoclax plus LDAC for adult AML patients at high risk of toxicity

Clinical challenge Acute myeloid leukemia (AML) patients ages 75 and older, and younger adults with comorbidities, are often ineligible to receive standard intensive chemotherapy due to high rates of toxicity and early mortality. As a [...]

View more

Search our entire site.